Victrex (LON:VCT) Stock Price Passes Above 200 Day Moving Average of $2,110.65

Share on StockTwits

Victrex plc (LON:VCT) shares crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2,110.65 and traded as high as $2,348.00. Victrex shares last traded at $2,340.00, with a volume of 227,466 shares.

Several research analysts have weighed in on VCT shares. Stifel Nicolaus lowered shares of Victrex to a “hold” rating and lowered their target price for the stock from GBX 2,255 ($29.47) to GBX 2,125 ($27.77) in a research report on Friday, September 27th. UBS Group restated a “neutral” rating on shares of Victrex in a research report on Monday, November 25th. Barclays reduced their price target on shares of Victrex from GBX 2,020 ($26.39) to GBX 1,940 ($25.35) and set an “equal weight” rating on the stock in a report on Wednesday, November 27th. Liberum Capital reaffirmed a “buy” rating on shares of Victrex in a report on Monday, October 7th. Finally, Peel Hunt reaffirmed a “hold” rating on shares of Victrex in a report on Monday, September 16th. Eight investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of GBX 2,261.50 ($29.55).

The company has a market cap of $2.03 billion and a PE ratio of 20.35. The firm’s fifty day simple moving average is GBX 2,287.72 and its 200-day simple moving average is GBX 2,110.65.

About Victrex (LON:VCT)

Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.

Further Reading: How to find the components of the quick ratio

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.